Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.
Saved in:
| Title: | Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report. |
|---|---|
| Authors: | Cable J; PhD Science Writer, New York, New York, USA., Fauci A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA., Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway., Günther S; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany., Bente DA; University of Texas Medical Branch, Galveston National Laboratory, Galveston, Texas, USA.; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Yadav PD; Indian Council of Medical Research-National Institute of Virology, Pune, India., Madoff LC; Department of Medicine, University of Massachusetts Chan School of Medicine, Worcester, Massachusetts, USA., Wang LF; Duke-NUS Medical School, Singapore., Arora RK; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.; Institute of Biomedical Engineering, University of Oxford, Oxford, UK., Van Kerkhove M; World Health Organization, Geneva, Switzerland., Chu MC; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA., Jaenisch T; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA., Epstein JH; EcoHealth Alliance, New York, New York, USA., Frost SDW; Microsoft Research, Redmond, Washington, USA., Bausch DG; FIND, the global alliance for diagnostics, Geneva, Switzerland., Hensley LE; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA., Bergeron É; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sitaras I; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Gunn MD; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Geisbert TW; University of Manitoba, Winnipeg, Manitoba, Canada.; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany., Krammer F; Department of Microbiology and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., de Wit E; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA., Nordenfelt P; Department of Clinical Sciences Lund, Infection Medicine, Faculty of Medicine, Lund University, Lund, Sweden., Saphire EO; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Gilbert SC; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Corbett KS; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Branco LM; Zalgen Labs, Germantown, Maryland, USA., Baize S; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Lyon, France.; INSERM, Ecole Normale Supérieure de Lyon, Université de Lyon, Lyon, France., van Doremalen N; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA., Krieger MA; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation - Paraná, Curitiba, Brazil.; Integrated Translational Program in Chagas Disease from Fiocruz (Fio-Chagas), Oswaldo Cruz Foundation - Rio de Janeiro, Rio de Janeiro, Brazil., Clemens SAC; Oxford Vaccine Group, Oxford University, Oxford, UK.; Institute for Global Health, University of Siena, Siena, Italy., Hesselink R; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway., Hartman D; Bill & Melinda Gates Foundation, Seattle, Washington, USA. |
| Source: | Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2022 Dec; Vol. 1518 (1), pp. 209-225. Date of Electronic Publication: 2022 Oct 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: New York Academy of Sciences Country of Publication: United States NLM ID: 7506858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1749-6632 (Electronic) Linking ISSN: 00778923 NLM ISO Abbreviation: Ann N Y Acad Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
